Infant Respiratory Interface and Accessories Evaluation Study
NCT ID: NCT05719298
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2023-02-28
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
NCT02814994
Volume Responsiveness Before SBT Predicts the Outcome of Mechanical Ventilation Weaning in Critically Ill Patients
NCT01867853
Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease
NCT02278107
Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress Syndrome
NCT04156438
Predictive Analysis Software for Successful Weaning From Ventilator of Patients
NCT02915458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Respiratory interface
Use of the new respiratory interface and accessories to deliver non-invasive therapy
Respiratory interface
Application of the new interface and accessories and provision of non-invasive respiratory support through the device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Respiratory interface
Application of the new interface and accessories and provision of non-invasive respiratory support through the device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parent(s)/guardian(s) at least 18 years of age
Exclusion Criteria
* Neonate or infant not requiring non-invasive support
* Suspected or confirmed abnormalities or trauma to the skull or airway
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mater Mothers' Hospital NICU
Brisbane, Queensland, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIA-235
Identifier Type: OTHER
Identifier Source: secondary_id
UT-1111-1267-0940
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.